TNF and neoplasm: M1 TAMs exert anti-tumor effects through the release of pro-inflammatory cytokines (IL-1, IL-6, IL-23, TNF-α), whereas M2 TAMs may drive local immune suppression by producing IL-10 and TGF-β.